BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9392928)

  • 1. The approach to treatment of invasive pneumococcal disease in the 1990s.
    Knapp KM; Schutze GE
    J Ark Med Soc; 1997 Nov; 94(6):263-6. PubMed ID: 9392928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumococcal antibiotic resistance].
    Moreillon P; Wenger A; Caldelari I
    Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
    Frick PA; Black DJ; Duchin JS; Deliganis S; McKee WM; Fritsche TR
    West J Med; 1998 Dec; 169(6):364-9. PubMed ID: 9866434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin-nonsusceptible Streptococcus pneumoniae infections in children.
    Lu CY; Lee PI; Hsueh PR; Chang SC; Chiu TF; Lin HC; Lee CY; Huang LM
    J Microbiol Immunol Infect; 1999 Sep; 32(3):179-86. PubMed ID: 10637716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
    Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP
    WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M; Mejía GI; Trujillo H; Robledo J
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal susceptibility to meropenem in a mid-south children's hospital.
    Buckingham SC; Davis Y; English BK
    South Med J; 2002 Nov; 95(11):1293-6. PubMed ID: 12539996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic resistance in pneumococci].
    Moreillon P; Wenger A
    Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs].
    Mihajlović-Ukropina M; Milutinović M
    Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae: bacteremia in an era of penicillin resistance.
    Castillo EM; Rickman LS; Brodine SK; Ledbetter EK; Kelly C
    Am J Infect Control; 2000 Jun; 28(3):239-43. PubMed ID: 10840344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae--New York City, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(14):297-9. PubMed ID: 9132581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A significant increase in antimicrobial resistance among pneumococci causing invasive disease in New Zealand.
    Brett MS; Martin DR
    N Z Med J; 1999 Apr; 112(1085):113-5. PubMed ID: 10326798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998.
    Chokephaibulkit K; Srifuengfung S; Mingbanjerdsuk J; Tosasuk K; Vanprapar N; Chearskul S; Dhiraputra C
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):498-505. PubMed ID: 11289009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of penicillin-resistant Streptococcus pneumoniae--Connecticut, 1992-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(12):216-7, 223. PubMed ID: 8127327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillin resistant Streptococcus pneumoniae isolates in Harare, Zimbabwe.
    Simango C; Mvududu F
    Cent Afr J Med; 1999 Apr; 45(4):100-2. PubMed ID: 10746390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(41):1077-80. PubMed ID: 17947966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.